Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
Vertex announces European Commission approval of an expanded indication for one of our
#cysticfibrosis medicines. Learn more: http://bit.ly/2P7DjdV pic.twitter.com/yORKrm0756
-
.
@CRISPRTX and@VertexPharma announce early positive data from first two patients treated with their investigational CRISPR/Cas9 gene editing therapy for sickle cell disease and beta thalassemia. http://bit.ly/2QDWRbj pic.twitter.com/ILOcOiSd20
-
.
@VertexPharma confirms Wales offer accepted for access to all licensed#cysticfibrosis medicines: http://bit.ly/2CHNQ8E pic.twitter.com/8R0i6tVcVJ
-
Vertex Reports Third-Quarter 2019 Financial Results http://bit.ly/2JAdYX6 pic.twitter.com/oEaX5clEE0
-
We will announce the Q3 2019 financial results on October 30. Dial-in information can be found here: http://bit.ly/2pY0i11 pic.twitter.com/j22b3mg8g0
-
Vertex announces agreement with NHS England for access to licensed
#cysticfibrosis medicines. Learn more: http://bit.ly/31N9J0J pic.twitter.com/M3TschCPIm
-
U.S.
#FDA approves new medicine to treat eligible people with#cysticfibrosis. Learn more: http://bit.ly/2p4SZV4 pic.twitter.com/2IDTx3hALS
-
#Breaking U.S.#FDA approves@VertexPharma#cysticfibrosis treatment. Learn more: http://bit.ly/2p4SZV4 pic.twitter.com/YoKYTBxm61
-
Vertex to Acquire Semma Therapeutics With a Goal of Developing Curative Cell-Based Treatments for Type 1 Diabetes http://bit.ly/2kfBYW9 pic.twitter.com/o0inXUN6lu
-
#Breaking U.S. FDA Accepts New Drug Application for Triple Combination Regimen in#cysticfibrosis#CF Learn more: http://bit.ly/2P84p6M pic.twitter.com/fezAhbkeVA
-
Our Q2 2019 earnings conference call & webcast is today at 4:30 p.m. ET. Dial-in information can be found here: http://bit.ly/3319iS5 pic.twitter.com/OrQhfPmTfq
-
#Breaking New Drug Application Submitted to the U.S. FDA for Triple Combination Regimen in#cysticfibrosis Learn more: http://bit.ly/2XUYpCA pic.twitter.com/M3xeVZ5cTw
-
We will announce the Q2 2019 financial results on July 31. Dial-in information can be found here: http://bit.ly/32z3AXy pic.twitter.com/0myl9U8kvg
-
We're excited to congratulate Dr. Peter Grootenhuis on his induction into the
@AmerChemSociety, MEDI Hall of Fame, an achievement fewer than 100 scientists have received since 1966, for his outstanding work in#cysticfibrosis research. Learn more: http://bit.ly/2XFL9MT pic.twitter.com/KQgvkcxVnY
-
We announced FDA approval of an expanded indication for one of our
#cysticfibrosis medicines. Learn more: http://bit.ly/2IXbLDX pic.twitter.com/IqktmMRGBp
-
We announced FDA approval of an expanded indication for one of our
#cysticfibrosis medicines. Learn more: http://bit.ly/2IXbLDX pic.twitter.com/3OcpAzbA6S
-
June is
#Pride month! Employees at Vertex that are part of the employee resource network, PRIDE, talk about the inclusiveness at the company.#GreatPlaceToWorkpic.twitter.com/qyBUUHF1Ku -
It was great to welcome students from the GAP Summit, an annual student-run biotechnology leadership summit, to our
#Boston office for a panel on potential career paths in#biotech. Learn more about our early career programs: http://bit.ly/31N0aQf#STEAMpic.twitter.com/W9zZlbj7yU
-
Excited to rank 4th on the
@BosBizJournal Best Places to Work List in the Extra Large Business Category! Thanks to our dedicated employees who make@VertexPharma such a fantastic place to work.#BBJBestPlaces@BosBizEventspic.twitter.com/bOFl32eVeG
-
Today we’re shining the light on Sickle Cell Disease in honor of
#WorldSickleCellAwarenessDay. We’re proud to be wearing t-shirts alongside our partner at@CRISPRTX and the@SCDAA.org to raise awareness. Use the hashtag#WorldSickleCellAwarenessDay to join in.pic.twitter.com/gtwknI23n5
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.